Northwestern Mutual Wealth Management CO Avidity Biosciences, Inc. Transaction History
Northwestern Mutual Wealth Management CO
- $118 Billion
- Q4 2024
A detailed history of Northwestern Mutual Wealth Management CO transactions in Avidity Biosciences, Inc. stock. As of the latest transaction made, Northwestern Mutual Wealth Management CO holds 14 shares of RNA stock, worth $431. This represents 0.0% of its overall portfolio holdings.
Number of Shares
14
Previous 40
65.0%
Holding current value
$431
Previous $1,000
100.0%
% of portfolio
0.0%
Previous 0.0%
Shares
6 transactions
Others Institutions Holding RNA
# of Institutions
258Shares Held
108MCall Options Held
517KPut Options Held
717K-
Price T Rowe Associates Inc Baltimore, MD11MShares$341 Million0.04% of portfolio
-
Vanguard Group Inc Valley Forge, PA9.43MShares$291 Million0.0% of portfolio
-
Black Rock Inc. New York, NY8.62MShares$266 Million0.01% of portfolio
-
Wellington Management Group LLP Boston, MA8.11MShares$250 Million0.04% of portfolio
-
Rtw Investments, LP New York, NY7.93MShares$245 Million3.76% of portfolio
About Avidity Biosciences, Inc.
- Ticker RNA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 52,127,000
- Market Cap $1.61B
- Description
- Avidity Biosciences, Inc., a biopharmaceutical company, engages in the development of oligonucleotide-based therapies. It develops antibody oligonucleotide conjugates (AOC) that are designed to treat a range of serious diseases. The company's lead product candidate AOC 1001 is used for the treatment of myotonic dystrophy type 1, a rare monogenic...